FARRELL PETER C 4
4 · RESMED INC · Filed Nov 18, 2025
Insider Transaction Report
Form 4
RESMED INCRMD
FARRELL PETER C
Director
Transactions
- Exercise/Conversion
ResMed Common Stock
2025-11-14$101.64/sh+11,442$1,162,965→ 77,552 total - Tax Payment
ResMed Common Stock
2025-11-14$244.46/sh−7,314$1,787,980→ 70,238 total - Exercise/Conversion
ResMed Common Stock Options
2025-11-14−11,442→ 0 totalExercise: $101.64From: 2019-11-11Exp: 2025-11-14→ ResMed Common Stock (11,442 underlying)
Footnotes (3)
- [F1]Transaction represents Options automatically exercised pursuant to the award terms. Options are vested in full.
- [F2]Disposition to issuer for tax withholding and cost to exercise the options granted on 11/14/2018.
- [F3]Transaction represents Options automatically exercised pursuant to the award terms. Options are vested in full.